Peanuts are a leading cause of immunoglobulin E (IgE)-mediated food allergies, especially anaphylactic reactions, in children. A landmark 2015 study called the Learning Early About Peanut Allergy (LEAP) trial demonstrated that introducing peanuts to infants aged 4-11 months with severe eczema or egg allergy reduced their risk of peanut allergy by 81%.
This protective effect extended beyond early childhood, supporting the hypothesis that early exposure to food antigens can prevent IgE-mediated food allergies.
Following these findings, major pediatric and allergy organizations released clinical guidelines beginning in 2015, first targeting high-risk infants and later expanding in 2021 to recommend early introduction of peanuts, eggs, and other allergens at 4-6 months for all infants without prior allergic reactions.
Significant Decline in Food Allergy Diagnoses
New research from the Children’s Hospital of Philadelphia using multi-state electronic health record data reveals a significant decline in peanut and other IgE-mediated food allergy diagnoses following the guideline implementation. The prevalence of peanut allergies in the studied population decreased from 0.79% to 0.45%, while overall IgE-mediated food allergies dropped from 1.46% to 0.93%.
Peanut has shifted from being the most common allergen to the second, with egg allergies now more prevalent. It is estimated that for every 200 infants exposed early to food allergens, one child is prevented from developing an allergy. These reductions substantiate the effectiveness of early introduction as a public health measure to reduce childhood food allergies.
Public Health Implications and Recommendations
The observed decline in diagnosis rates underscores the success of translating landmark research into public health practice. Experts emphasize the need for ongoing awareness, education, and advocacy to increase adherence to early introduction guidelines. Feeding infants small, safe amounts of allergenic foods such as peanut butter or yogurt is encouraged to promote immune tolerance.
Although early introduction does not completely eliminate all food allergies, especially severe cases, it represents a major advancement in allergy prevention. Future studies are needed to refine optimal timing, frequency, and dosage of allergen exposure for maximum protection against food allergies.
Study Support and Funding
This research was supported by various institutions including the National Institutes of Health, the Hartwell Foundation, the American Academy of Allergy Asthma and Immunology, and the Food Allergy Fund, highlighting the collaborative effort to improve outcomes for children with food allergies and to explore underlying causes and better treatments.
These findings provide compelling evidence that early dietary introduction of peanuts and other allergens is a transformative approach to reducing food allergy incidence, marking an important shift in pediatric allergy prevention strategies.
Related topics
